Enjoy complimentary customisation on priority with our Enterprise License!
The red biotechnology market size is forecast to increase by USD 174.56 billion at a CAGR of 6.23% between 2023 and 2028. The market is experiencing significant growth due to the increasing focus on medical innovations and healthcare solutions for chronic diseases. Genetic factors play a crucial role in driving the demand for red biotechnology, particularly in the development of monoclonal antibodies and gene therapy products. Advancements in genomic research and the high development costs of red biotechnology methods are key growth factors. Rising stem cell research and therapies also contribute to the market's expansion. As medical biotechnology continues to evolve, the industry is expected to bring forth groundbreaking healthcare solutions for various conditions. The market's future looks promising, with numerous opportunities for companies to invest and innovate.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.